5. Pacific Biosciences of California, Inc. (PACB): Develops, manufactures, and markets an integrated platform for genetic analysis. Market cap of $229.54M. Mean average rating changed from 2.25 to 2.38 between 06/22/11 and 07/22/11 (bearish change). Analysts correctly predicted the direction of the stock over the next month, with the stock generating an alpha of -36.19%.
Analysts also got it right between 07/22/11 and 08/21/11, with the mean rating changing from 2.38 to 2.5 (bearish change). Over the following month, the stock generated an alpha of -10.1% relative to the S&P 500 index, as predicted by the analysts.
This same group of analysts now expect the stock to outperform in the future, with the mean rating changing from 2.5 to 2.43 between 08/21/11 and 09/20/11 (i.e. bullish change).
The stock is a short squeeze candidate, with a short float at 8.33% (equivalent to 9.18 days of average volume). The stock is currently stuck in a downtrend, trading 30.84% below its SMA20, 46.17% below its SMA50, and 64.88% below its SMA200. It's been a rough couple of days for the stock, losing 28.93% over the last week.
PACB didn't work, but that doesn't mean there was criminal activity. I swear, when people lose money it's always somebody else's fault. This company was years away from being profitable, unproven and expensive, etc. Yet people bought it anyway just hoping it would all work out and now they have to sue somebody, because nobody can take responsibility for their own decisions anymore.